| Company Name: |
Cool Pharm, Ltd |
| Tel: |
021-58581007 18019463053 |
| Email: |
sales@coolpharm.com |
| Company Name: |
Energy Chemical |
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt manufacturers
|
| | 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt Basic information |
| Product Name: | 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt | | Synonyms: | 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt;8,9-Dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one hydrochloride;(Rac)-WAY-161503 (hydrochloride) | | CAS: | 276695-22-8 | | MF: | C11H12Cl3N3O | | MW: | 308.59148 | | EINECS: | | | Product Categories: | | | Mol File: | 276695-22-8.mol | ![8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt Structure](CAS/20150408/GIF/276695-22-8.gif) |
| | 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt Chemical Properties |
| storage temp. | room temp | | solubility | DMSO: >10mg/mL | | form | powder | | color | white to off-white | | InChI | 1S/C11H11Cl2N3O.ClH/c12-6-3-8-9(4-7(6)13)16-2-1-14-5-10(16)11(17)15-8;/h3-4,10,14H,1-2,5H2,(H,15,17);1H | | InChIKey | YPNWSZJDAKOUAW-UHFFFAOYSA-N | | SMILES | Cl.Clc1cc2NC(=O)C3CNCCN3c2cc1Cl |
| WGK Germany | nwg | | Storage Class | 11 - Combustible Solids |
| | 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt Usage And Synthesis |
| Uses | WAY 161503 Hydrochloride is a potent serotonin 5-HT2C receptor agonist with antiobesity effects. It is the salt analogue of WAY 161503 (D437235). | | Biological Activity | The 5-HT2C receptors have been implicated in conditions including obesity, anxiety, depression, OCD, schizophrenia, migraine, nociception and erectile dysfunction. | | in vivo | (Rac)-WAY-161503 (3-30 mg/kg; i.p.; male C57BL/6J mice) hydrochloride dose-dependently decreases locomotor activity, an effect that is blocked by the 5-HT2C/2B antagonist SER-082[1].
| Animal Model: | Male C57BL/6J mice with hallucinogen 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)[1] | | Dosage: | 3 mg/kg, 10 mg/kg, 30 mg/kg | | Administration: | Intraperitoneal injection (i.p.) | | Result: | Antagonized the PGE2-mediated inhibition of LPS-induced TNF-α release from rat whole blood culture, in a dose-dependent way. |
| | IC 50 | 5-HT2C Receptor: 4 nM (Ki); 5-HT2C Receptor: 12 nM (EC50) | | storage | Desiccate at RT |
| | 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride salt Preparation Products And Raw materials |
|